{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023111","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.761947+00:00","generated_at":"2026-06-01T05:41:25.029495+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PowerUp Acquisition amends merger with Visiox: Outside Date extended to June 30, 2024","bullets":["Outside Date moved from May 31 to June 30, 2024; PowerUp's indebtedness cap increased to $2M.","Net tangible asset test eliminated; minimum cash condition reduced from $5M to $1.00.","Visiox must use best efforts to complete labeling/compliance for inventory by June 30, 2024.","Visiox must raise at least $500K capital by June 30; $350K allocated to labeling project.","From May 30 to closing, Visiox cannot make expenditures over $1K without PowerUp's approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023111","json":"https://secwatch.observer/filing/0001493152-24-023111.json","markdown":"https://secwatch.observer/filing/0001493152-24-023111.md","text":"https://secwatch.observer/filing/0001493152-24-023111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/0001493152-24-023111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:41:25.029495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}